The results above, coupled with the correlation of high CBFβ levels with metastatic behavior in breast, prostate, and ovarian cancer cells, support the notion that high CBFβ expression in the primary tumor may contribute to metastatic behavior. This evidence concerns the gene CBFB and ovarian carcinoma.